Conversely, the PI3K inhibitor LY294002 (which prevents phosphorylation and activation of Akt) enhanced paclitaxel-induced apoptosis in vitro and in vivo in ovarian cancer [27]. This evidence concerns the gene PIK3CA and ovarian carcinoma.